Search Results Search Sort by RelevanceMost Recent Health Law Nov 2021 Should Employment Division v Smith Be Overturned? Jake Greenblum, PhD and Ryan Hubbard, PhD Overturning this case’s precedent might result in clinicians claiming more religious exemptions and increased risk of harm to patients. AMA J Ethics. 2021;23(11):E864-868. doi: 10.1001/amajethics.2021.864. Health Law Dec 2021 How Has American Constitutional Law Influenced Medical School Admissions and Thwarted Health Justice? Scott J. Schweikart, JD, MBE The US Supreme Court has allowed race-conscious admissions when a school’s purpose is to diversify an incoming class but not to remediate inequity. AMA J Ethics. 2021;23(12):E953-959. doi: 10.1001/amajethics.2021.953. Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010. Podcast Nov 2021 Author Interview: “Should Employment Division v Smith Be Overturned?” Dr Jake Greenblum joins Ethics Talk to discuss his article, coauthored with Dr Ryan Hubbard: “Should Employment Division v Smith Be Overturned?” Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Health Law Nov 2021 Should Employment Division v Smith Be Overturned? Jake Greenblum, PhD and Ryan Hubbard, PhD Overturning this case’s precedent might result in clinicians claiming more religious exemptions and increased risk of harm to patients. AMA J Ethics. 2021;23(11):E864-868. doi: 10.1001/amajethics.2021.864.
Health Law Dec 2021 How Has American Constitutional Law Influenced Medical School Admissions and Thwarted Health Justice? Scott J. Schweikart, JD, MBE The US Supreme Court has allowed race-conscious admissions when a school’s purpose is to diversify an incoming class but not to remediate inequity. AMA J Ethics. 2021;23(12):E953-959. doi: 10.1001/amajethics.2021.953.
Medical Education Dec 2020 How Educators Can Help Prevent False Brain Death Diagnoses Farah Fourcand, MD and Diana M. Barratt, MD, MPH For many physicians, lack of understanding about brain death leads to confusion and muddles interactions with patients’ loved ones at the end of life. AMA J Ethics. 2020;22(12):E1010-1018. doi: 10.1001/amajethics.2020.1010.
Podcast Nov 2021 Author Interview: “Should Employment Division v Smith Be Overturned?” Dr Jake Greenblum joins Ethics Talk to discuss his article, coauthored with Dr Ryan Hubbard: “Should Employment Division v Smith Be Overturned?”
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 1 Amy Haddad, PhD, RN Virtual Mentor. 2002;4(11):320-323. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
Case and Commentary Nov 2002 Patients Who Can't Afford Drugs, Commentary 2 Audiey Kao, MD, PhD Virtual Mentor. 2002;4(11):324-326. doi: 10.1001/virtualmentor.2002.4.11.ccas1-0211.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.